Abbott Laboratories (ABT)

Abbott Laboratories Stock Forecast

Stock Price Forecast

The 19 analysts that cover Abbott Laboratories stock have a consensus rating of "Strong Buy" and an average price target of $142.79, which forecasts a 12.84% increase in the stock price over the next year. The lowest target is $120 and the highest is $160.

Price Target: $142.79 (+12.84%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$120	$142.79	$145	$160
Change	-5.17%	+12.84%	+14.59%	+26.44%

Analyst Ratings

The average analyst rating for Abbott Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	5	6	6	6	6	8
Buy	8	8	8	8	8	8
Hold	4	4	4	4	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	18	18	18	18	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lawrence Biegelsen Wells Fargo	Wells Fargo	Buy Maintains $147 → $142	Buy	Maintains	$147 → $142	+12.22%	Jul 18, 2025
Jayson Bedford Raymond James	Raymond James	Buy Maintains $142 → $141	Buy	Maintains	$142 → $141	+11.43%	Jul 18, 2025
Anthony Petrone Mizuho	Mizuho	Hold Maintains $140 → $135	Hold	Maintains	$140 → $135	+6.69%	Jul 18, 2025
Matthew Taylor Jefferies	Jefferies	Hold → Strong Buy Upgrades $143 → $145	Hold → Strong Buy	Upgrades	$143 → $145	+14.59%	Jul 18, 2025
Marie Thibault BTIG	BTIG	Strong Buy Maintains $148 → $145	Strong Buy	Maintains	$148 → $145	+14.59%	Jul 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

45.12B

Increased by 7.56%

from 41.95B

Revenue Next Year

48.61B

Increased by 7.73%

from 45.12B

EPS This Year

5.21

Decreased by -31.78%

from 7.64

EPS Next Year

5.74

Increased by 10.20%

from 5.21

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	34.61B	43.08B	43.65B	40.11B	41.95B	45.12B	48.61B	52.28B
Revenue Growth	8.48%	24.47%	1.34%	-8.12%	4.59%	7.56%	7.73%	7.56%
EPS	2.50	3.94	3.91	3.26	7.64	5.21	5.74	6.34
EPS Growth	21.53%	57.38%	-0.76%	-16.62%	134.36%	-31.78%	10.20%	10.36%
Forward PE	-	-	-	-	-	24.28	22.03	19.96
No. Analysts	-	-	-	-	-	30	30	23

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	47.4B	51.5B	56.1B
Avg	45.1B	48.6B	52.3B
Low	43.3B	46.5B	49.8B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	12.9%	14.2%	15.3%
Avg	7.6%	7.7%	7.6%
Low	3.3%	3.0%	2.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	5.46	6.11	6.88
Avg	5.21	5.74	6.34
Low	5.00	5.45	5.91

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-28.5%	17.3%	19.8%
Avg	-31.8%	10.2%	10.4%
Low	-34.6%	4.5%	2.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.